Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Pathology of pancreatic stroma in PDAC.

Rasheed ZA, Matsui W, Maitra A.

In: Grippo PJ, Munshi HG, editors. Pancreatic Cancer and Tumor Microenvironment. Trivandrum (India): Transworld Research Network; 2012. Chapter 1.

2.

Pancreatic Cancer and Tumor Microenvironment.

Grippo PJ, Munshi HG, editors.

Trivandrum (India): Transworld Research Network; 2012.

3.

Bioinformatic analysis reveals pancreatic cancer molecular subtypes specific to the tumor and the microenvironment.

Le Large TY, Mato Prado M, Krell J, Bijlsma MF, Meijer LL, Kazemier G, Frampton AE, Giovannetti E.

Expert Rev Mol Diagn. 2016 Jul;16(7):733-6. doi: 10.1080/14737159.2016.1175940. Epub 2016 Apr 27.

PMID:
27118062
4.

Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.

Haqq J, Howells LM, Garcea G, Metcalfe MS, Steward WP, Dennison AR.

Eur J Cancer. 2014 Oct;50(15):2570-82. doi: 10.1016/j.ejca.2014.06.021. Epub 2014 Aug 1. Review.

PMID:
25091797
5.

Pathophysiological role of microRNA-29 in pancreatic cancer stroma.

Kwon JJ, Nabinger SC, Vega Z, Sahu SS, Alluri RK, Abdul-Sater Z, Yu Z, Gore J, Nalepa G, Saxena R, Korc M, Kota J.

Sci Rep. 2015 Jun 22;5:11450. doi: 10.1038/srep11450.

6.

Generation of an in vitro 3D PDAC stroma rich spheroid model.

Ware MJ, Keshishian V, Law JJ, Ho JC, Favela CA, Rees P, Smith B, Mohammad S, Hwang RF, Rajapakshe K, Coarfa C, Huang S, Edwards DP, Corr SJ, Godin B, Curley SA.

Biomaterials. 2016 Nov;108:129-142. doi: 10.1016/j.biomaterials.2016.08.041. Epub 2016 Sep 2.

PMID:
27627810
7.

Pancreatic cancer: the role of pancreatic stellate cells in tumor progression.

Dunér S, Lopatko Lindman J, Ansari D, Gundewar C, Andersson R.

Pancreatology. 2010;10(6):673-81. doi: 10.1159/000320711. Epub 2011 Jan 18. Review.

PMID:
21242706
8.

Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Mahadevan D, Von Hoff DD.

Mol Cancer Ther. 2007 Apr;6(4):1186-97. Epub 2007 Apr 3. Review.

9.

The stromal compartments in pancreatic cancer: are there any therapeutic targets?

Lunardi S, Muschel RJ, Brunner TB.

Cancer Lett. 2014 Feb 28;343(2):147-55. doi: 10.1016/j.canlet.2013.09.039. Epub 2013 Oct 16. Review.

PMID:
24141189
10.

Stars and stripes in pancreatic cancer: role of stellate cells and stroma in cancer progression.

Wilson JS, Pirola RC, Apte MV.

Front Physiol. 2014 Feb 14;5:52. doi: 10.3389/fphys.2014.00052. eCollection 2014. Review.

11.

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma.

Sato N, Cheng XB, Kohi S, Koga A, Hirata K.

Acta Pharm Sin B. 2016 Mar;6(2):101-5. doi: 10.1016/j.apsb.2016.01.002. Epub 2016 Jan 21. Review.

12.

Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma.

Damhofer H, Medema JP, Veenstra VL, Badea L, Popescu I, Roelink H, Bijlsma MF.

Mol Oncol. 2013 Dec;7(6):1031-42. doi: 10.1016/j.molonc.2013.08.004. Epub 2013 Aug 16.

13.

Role of pancreatic stellate cells and periostin in pancreatic cancer progression.

Liu Y, Du L.

Tumour Biol. 2015 May;36(5):3171-7. doi: 10.1007/s13277-015-3386-2. Epub 2015 Apr 4. Review.

PMID:
25840689
14.

Desmoplasia of pancreatic ductal adenocarcinoma.

Pandol S, Edderkaoui M, Gukovsky I, Lugea A, Gukovskaya A.

Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S44-7. doi: 10.1016/j.cgh.2009.07.039. Review.

15.

Imbalance of desmoplastic stromal cell numbers drives aggressive cancer processes.

Kadaba R, Birke H, Wang J, Hooper S, Andl CD, Di Maggio F, Soylu E, Ghallab M, Bor D, Froeling FE, Bhattacharya S, Rustgi AK, Sahai E, Chelala C, Sasieni P, Kocher HM.

J Pathol. 2013 May;230(1):107-17. doi: 10.1002/path.4172. Epub 2013 Mar 21.

16.

Key players in pancreatic cancer-stroma interaction: Cancer-associated fibroblasts, endothelial and inflammatory cells.

Nielsen MF, Mortensen MB, Detlefsen S.

World J Gastroenterol. 2016 Mar 7;22(9):2678-700. doi: 10.3748/wjg.v22.i9.2678. Review.

17.

Pancreatic cancer: The microenvironment needs attention too!

Apte MV, Xu Z, Pothula S, Goldstein D, Pirola RC, Wilson JS.

Pancreatology. 2015 Jul;15(4 Suppl):S32-8. doi: 10.1016/j.pan.2015.02.013. Epub 2015 Mar 21. Review.

PMID:
25845856
18.

Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.

Ene-Obong A, Clear AJ, Watt J, Wang J, Fatah R, Riches JC, Marshall JF, Chin-Aleong J, Chelala C, Gribben JG, Ramsay AG, Kocher HM.

Gastroenterology. 2013 Nov;145(5):1121-32. doi: 10.1053/j.gastro.2013.07.025. Epub 2013 Jul 25.

19.

Interaction of stellate cells with pancreatic carcinoma cells.

Habisch H, Zhou S, Siech M, Bachem MG.

Cancers (Basel). 2010 Sep 9;2(3):1661-82. doi: 10.3390/cancers2031661.

20.

Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight.

Sato N, Kohi S, Hirata K, Goggins M.

Cancer Sci. 2016 May;107(5):569-75. doi: 10.1111/cas.12913. Epub 2016 Mar 18. Review.

Items per page

Supplemental Content

Write to the Help Desk